Text Size

Carbachols Headache-inducing Effect and Changes in Cerebral Blood Flow in Migraine Patients

This study has been completed.
Sponsor:
Information provided by:
Danish Headache Center
ClinicalTrials.gov Identifier:
NCT00564408
First received: November 27, 2007
Last updated: July 31, 2009
Last verified: July 2009
History of Changes
  Purpose

The purpose of this study is to test if carbachol infusion induces headache in migraine subjects as well as intra- and extra-cerebral vasodilatation.


Condition Intervention
Headache
 Drug: Carbachol

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Pharmacodynamics Study
Intervention Model: Crossover Assignment
Masking: Double Blind (Subject, Investigator)
Primary Purpose: Basic Science
Official Title: Experimental Study That Investigates the Effect of an Acetylcholine Analogue in Terms of Headache and Changes in Intra- and Extra-cerebral Vessels During and After Infusion of Carbachol

Resource links provided by NLM:

MedlinePlus related topics: Headache Migraine
Drug Information available for: Carbachol
U.S. FDA Resources

Further study details as provided by Danish Headache Center:

Primary Outcome Measures:
  • Headache response after Carbachol infusion [ Time Frame: 1 day after infusion ] [ Designated as safety issue: No ]

Estimated Enrollment: 12
Study Start Date: August 2007
Study Completion Date: February 2009
Primary Completion Date: October 2008 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: I Drug: Carbachol
3 microgram per kg bodyweight infused intravenously

Detailed Description:

To test if infusion of Carbachol induces headache in 12 migraine subjects as well as intra- and extra-cerebral vasodilatation in a double-blinded study

  Eligibility

Ages Eligible for Study:   18 Years to 50 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Migraine without aura
  • Weight 50-100 kg

Exclusion Criteria:

  • Other significant diseases
  • Migraine 5 days prior to experiment
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00564408

Locations
Denmark
Danish Headache Center
Glostrup, Denmark, 2600
Sponsors and Collaborators
Danish Headache Center
Investigators
Principal Investigator: Henrik Schytz, MD Danish Headache Center
  More Information

No publications provided

Responsible Party: Henrik Schytz/MD, Danish HC
ClinicalTrials.gov Identifier: NCT00564408     History of Changes
Other Study ID Numbers: HC20070049
Study First Received: November 27, 2007
Last Updated: July 31, 2009
Health Authority: Denmark: Ethics Committee

Additional relevant MeSH terms:
Headache
Pain
Neurologic Manifestations
Nervous System Diseases
Signs and Symptoms
Carbachol
Cardiotonic Agents
Cardiovascular Agents
Therapeutic Uses
Pharmacologic Actions
Miotics
Autonomic Agents
 Peripheral Nervous System Agents
Physiological Effects of Drugs
Cholinergic Agonists
Cholinergic Agents
Neurotransmitter Agents
Molecular Mechanisms of Pharmacological Action
Analgesics, Non-Narcotic
Analgesics
Sensory System Agents
Central Nervous System Agents
Protective Agents

ClinicalTrials.gov processed this record on May 19, 2013